Aegis Capital Starts Akebia Therapeutics (AKBA) at Buy

November 15, 2016 7:35 AM EST
Get Alerts AKBA Hot Sheet
Price: $8.47 -0.12%

Rating Summary:
    8 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade AKBA Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Aegis Capital initiated coverage on Akebia Therapeutics (NASDAQ: AKBA) with a Buy rating and a price target of $18.00.

For an analyst ratings summary and ratings history on Akebia Therapeutics click here. For more ratings news on Akebia Therapeutics click here.

Shares of Akebia Therapeutics closed at $8.90 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Add Your Comment